Health Care Trxade (MEDS) betting big on its new health passport app 5 years ago With COVID-19 vaccination taking place on a full-fledged scale across the country, the Joe Biden administration had last month announced… Here’s what you need to know before investing in Amgen (AMGN) 5 years ago The coronavirus outbreak has made leading pharma companies channelize their resources for vaccine development, and the efforts have been largely… Walgreens Boots Alliance, Inc. (WBA) Q2 2021 Earnings Call Transcript 5 years ago Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q2 2021 earnings call dated Mar. 31, 2021 Corporate Participants: Gerald Gradwell -- Senior Vice President… Walgreens Boots Alliance (WBA) Earnings: Key financials and quarterly highlights 5 years ago Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported second-quarter 2021 earnings results today. Sales increased 4.6% to $32.8 billion. It is… AngioDynamics Inc (ANGO) Q3 2021 Earnings Call Transcript 5 years ago AngioDynamics Inc. (NASDAQ: ANGO) Q3 2021 earnings call dated Mar. 30, 2021. Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen… Trxade Group (MEDS) delivers annual revenue growth of 130% 5 years ago Trxade (NASDAQ: MEDS) on Monday posted a 17% increase in fourth-quarter revenues to $2 million, riding on the strength of… Neogen Corp (NEOG) Q3 2021 Earnings Call Transcript 5 years ago Neogen Corp (NASDAQ: NEOG) Q3 2021 earnings call dated Mar. 23, 2021. Corporate Participants: John Adent -- Chief Executive Officer and President… With a Phase 2 success, Entera Bio’s pipeline might be worth betting on 5 years ago Reporting by Arjun Vijay While rising interest in biotechnology has provided a much-needed fillip to the research and development of… Entera Bio Ltd. (ENTX) Q4 2020 Earnings Call Transcript 5 years ago Entera Bio Ltd. (NASDAQ: ENTX) Q4 2020 earnings call dated Mar. 18, 2021 Corporate Participants: Jonathan Lieber -- Chief Financial… Cipher Pharmaceuticals Inc. (CPH) Q4 2020 Earnings Call Transcript 5 years ago Cipher Pharmaceuticals Inc. (TSX: CPH) Q4 2020 earnings call dated Mar. 19, 2021 Corporate Participants: Craig Mull -- Interim Chief Executive Officer… Next» « Previous